Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2021

Sep 9, 2021

30786_dirs_2021-09-09_2ebe2194-bc61-41b3-b216-3b6d70701051.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2021-09-07

Reporting Person: ERNST TIMOTHY S (EVP, General Counsel & Sec)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-09-07 Bio-Rad A Common Stock M 500.00 Acquired 2401.0531 Direct
2021-09-07 Bio-Rad A Common Stock F 248.00 $806.32 Disposed 2153.0531 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-09-07 Restricted Stock Units $0 M 500 Disposed Bio-Rad A Common Stock (500) Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: On September 7, 2016, the reporting person was granted 2,500 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.